News | June 25, 2024
Sun Pharma completes Taro merger
Combined entity is better positioned to compete in increasingly competitive generics industry
Combined entity is better positioned to compete in increasingly competitive generics industry
The facility was inspected from May 7 to May 17, 2024
The consultative meet, a first of its kind, will bring together representatives from diverse domains of Traditional Medicine (TM) in India
_256_384.jpg)
The company will work closely with the USFDA and is committed to address these comprehensively within stipulated time
Second FDA approval for KRAZATI - reinforcing its potential across tumor types
Dabigatran Etexilate Capsules are indicated for reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation in adult patients
_256_384.jpg)
Cipla had earlier invested € 15 million in Ethris in 2022
Lenire is the first and only bimodal neuromodulation device to be awarded a Federal Supply Schedule (FSS) Contract from the US Government
Detailed data from Phase 3 ECHELON-3 study demonstrate investigational ADCETRIS regimen reduced risk of death by 37 percent compared to chemotherapy alone
Abdel has held leadership positions at Bayer, Merck, Catalent, Lonza, and KBI Biopharma,
Subscribe To Our Newsletter & Stay Updated
